High Point Bank & Trust’s Teva Pharmaceuticals TEVA Stock Holding History

High Point Bank & Trust’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$89K	Buy	2,452 +200	+9%	+$7.99K	0.03%	181
2016 Q3	$104K	Hold	2,252	–	–	0.03%	177
2016 Q2	$113K	Sell	2,252 -800	-26%	-$42.6K	0.03%	164
2016 Q1	$163K	Hold	3,052	–	–	0.04%	142
2015 Q4	$200K	Hold	3,052	–	–	0.05%	130
2015 Q3	$172K	Hold	3,052	–	–	0.05%	144
2015 Q2	$180K	Hold	3,052	–	–	0.05%	148
2015 Q1	$190K	Hold	3,052	–	–	0.06%	146
2014 Q4	$176K	Hold	3,052	–	–	0.06%	152
2014 Q3	$164K	Sell	3,052 -650	-18%	-$34.4K	0.05%	152
2014 Q2	$194K	Hold	3,702	–	–	0.06%	150
2014 Q1	$196K	Hold	3,702	–	–	0.06%	149
2013 Q4	$148K	Hold	3,702	–	–	0.05%	155
2013 Q3	$140K	Hold	3,702	–	–	0.05%	166
2013 Q2	$145K	Buy	+3,702	New	+$144K	0.05%	158

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

High Point Bank & Trust's TEVA Position: Q4 2016 in Review

High Point Bank & Trust increased its Teva Pharmaceuticals (TEVA) stake by 8.9% in Q4 2016, buying an estimated $7.99K and bringing the position to 2,452 shares worth $89K. The position accounts for 0.03% of the portfolio, ranked #181.

High Point Bank & Trust first reported a position in TEVA in Q2 2013 and has held it in 15 quarters since. The position peaked at $200K in Q4 2015. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

High Point Bank & Trust held 2,452 shares of Teva Pharmaceuticals worth $89K as of Q4 2016.
High Point Bank & Trust bought 200 Teva Pharmaceuticals shares in Q4 2016, an estimated $7.99K.
Teva Pharmaceuticals made up 0.03% of High Point Bank & Trust's portfolio in Q4 2016, its #181 holding.
High Point Bank & Trust first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
High Point Bank & Trust's Teva Pharmaceuticals position peaked at $200K in Q4 2015.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on High Point Bank & Trust's 13F filing for Q4 2016, filed 28 Feb 2017.